A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Tango Therapeutics, Inc.
PharmaMar
NGM Biopharmaceuticals, Inc
Shenzhen BinDeBio Ltd.